ELAN
Price
$24.17
Change
+$0.12 (+0.50%)
Updated
Jun 12 closing price
Capitalization
12.07B
57 days until earnings call
Intraday BUY SELL Signals
PRGO
Price
$10.99
Change
+$0.09 (+0.83%)
Updated
Jun 12 closing price
Capitalization
1.52B
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELAN vs PRGO

Header iconELAN vs PRGO Comparison
Open Charts ELAN vs PRGOBanner chart's image
ELAN vs PRGO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ELAN vs. PRGO commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a StrongBuy and PRGO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2026
Stock price -- (ELAN: $24.17 vs. PRGO: $10.99)
Brand notoriety: ELAN: Notable vs. PRGO: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ELAN: 74% vs. PRGO: 122%
Market capitalization -- ELAN: $12.07B vs. PRGO: $1.52B
ELAN [@Pharmaceuticals: Generic] is valued at $12.07B. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $1.52B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 1 FA rating(s) are green whilePRGO’s FA Score has 1 green FA rating(s).

  • ELAN’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, PRGO is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 6 TA indicator(s) are bullish while PRGO’s TA Score has 4 bullish TA indicator(s).

  • ELAN’s TA Score: 6 bullish, 3 bearish.
  • PRGO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ELAN is a better buy in the short-term than PRGO.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а +2.29% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was +1.48% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.56%. For the same industry, the average monthly price growth was +23.25%, and the average quarterly price growth was +9.77%.

Reported Earning Dates

ELAN is expected to report earnings on Aug 10, 2026.

PRGO is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.56% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($12.1B) has a higher market cap than PRGO($1.52B). PRGO has higher P/E ratio than ELAN: PRGO (2818.00) vs ELAN (374.14). ELAN YTD gains are higher at: 6.805 vs. PRGO (-17.179). ELAN has higher annual earnings (EBITDA): 731M vs. PRGO (-1.21B). ELAN has more cash in the bank: 428M vs. PRGO (357M). PRGO has less debt than ELAN: PRGO (3.63B) vs ELAN (3.99B). ELAN has higher revenues than PRGO: ELAN (4.89B) vs PRGO (4.18B).
ELANPRGOELAN / PRGO
Capitalization12.1B1.52B796%
EBITDA731M-1.21B-60%
Gain YTD6.805-17.179-40%
P/E Ratio374.142818.0013%
Revenue4.89B4.18B117%
Total Cash428M357M120%
Total Debt3.99B3.63B110%
FUNDAMENTALS RATINGS
ELAN vs PRGO: Fundamental Ratings
ELAN
PRGO
OUTLOOK RATING
1..100
305
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9399
PRICE GROWTH RATING
1..100
4359
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
3655

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (34) in the Pharmaceuticals Other industry is somewhat better than the same rating for ELAN (93) in the Agricultural Commodities Or Milling industry. This means that PRGO’s stock grew somewhat faster than ELAN’s over the last 12 months.

PRGO's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that PRGO’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's SMR Rating (93) in the Agricultural Commodities Or Milling industry is in the same range as PRGO (99) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to PRGO’s over the last 12 months.

ELAN's Price Growth Rating (43) in the Agricultural Commodities Or Milling industry is in the same range as PRGO (59) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to PRGO’s over the last 12 months.

ELAN's P/E Growth Rating (1) in the Agricultural Commodities Or Milling industry is in the same range as PRGO (2) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to PRGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANPRGO
RSI
ODDS (%)
Bearish Trend 7 days ago
70%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
74%
MACD
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
59%
Advances
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 7 days ago
61%
Declines
ODDS (%)
Bearish Trend 13 days ago
74%
Bearish Trend 4 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
77%
Bearish Trend 3 days ago
71%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
ELAN
Daily Signal:
Gain/Loss:
PRGO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FSML29.690.36
+1.22%
Franklin Small Cap Enhanced ETF
BTOT49.530.22
+0.44%
iShares Total USD Fixed Income MarketETF
FEBP33.810.09
+0.26%
PGIM S&P 500 Buffer 12 ETF - Feb
SPIP25.69-0.02
-0.08%
State Street® SPDR® Portfolio TIPS ETF
VPV11.37-0.13
-1.13%
Invesco Pennsylvania Value Municipal Income Trust

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with PAHC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
+0.50%
PAHC - ELAN
45%
Loosely correlated
+0.86%
ZTS - ELAN
45%
Loosely correlated
-2.25%
VTRS - ELAN
41%
Loosely correlated
+1.04%
SNDL - ELAN
39%
Loosely correlated
-2.74%
AMRX - ELAN
36%
Loosely correlated
-0.86%
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with EVO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then EVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
+0.83%
EVO - PRGO
40%
Loosely correlated
N/A
SUPN - PRGO
38%
Loosely correlated
-2.50%
ELAN - PRGO
32%
Poorly correlated
+0.50%
ZTS - PRGO
31%
Poorly correlated
-2.25%
ORGO - PRGO
31%
Poorly correlated
-1.68%
More